tetano
Editor, Senior Moderator
Virol J
. 2024 Jan 23;21(1):26.
doi: 10.1186/s12985-023-02282-x. A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity
Wipawee Nittayananta[SUP] 1 [/SUP], Hatairat Lerdsamran[SUP] 2 [/SUP], Nopporn Chutiwitoonchai[SUP] 3 [/SUP], Aornrutai Promsong[SUP] 4 [/SUP], Teerapol Srichana[SUP] 5 6 [/SUP], Kesinee Netsomboon[SUP] 7 [/SUP], Jarunee Prasertsopon[SUP] 2 [/SUP], Jaruta Kerdto[SUP] 8 [/SUP]
Affiliations
Background: Infection by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and influenza virus is still a major worldwide health concern. Plants are a good source of bioactive compounds to be used as preventive measures for both inhibiting the virus binding and enhancing mucosal innate immunity. Curcumin has been shown to possess antiviral activity and modulate innate immunity. Therefore, the purpose of this study was to develop an oro-nasal film spray containing curcumin and determine its antiviral activity against SARS-CoV-2 and influenza virus infection, as well as its effects on mucosal innate immunity and inflammatory cytokines in vitro.
Methods: The antiviral activity of the film spray against SARS-CoV-2, influenza A/H1N1, A/H3N2, and influenza B was assessed in vitro by plaque reduction assay. Cytotoxicity of the film spray to oral keratinocytes and nasal epithelial cells was assessed by MTT assay, and cytotoxicity to Vero and MDCK cells was assessed by an MTS-based cytotoxicity assay. Oral and nasal innate immune markers in response to the film spray were determined by ELISA and by a commercial Milliplex Map Kit, respectively.
Results: Our data show that the film spray containing curcumin can inhibit both SARS-CoV-2 and influenza virus infections while maintaining cell viability. Results obtained among 4 viruses revealed that curcumin film spray demonstrated the highest inhibitory activity against SARS-CoV-2 with the lowest EC[SUB]50[/SUB] of 3.15 µg/ml and the highest SI value of 4.62, followed by influenza B (EC[SUB]50[/SUB] = 6.32 µg/ml, SI = 2.04), influenza A/H1N1 (EC[SUB]50[/SUB] = 7.24 µg/ml, SI = 1.78), and influenza A/H3N2 (EC[SUB]50[/SUB] > 12.5 µg/ml, SI < 1.03), respectively. Antimicrobial peptides LL-37 and HD-5, IL-6 and TNF-α produced by oral keratinocytes were significantly induced by the film spray, while hBD2 was significantly reduced.
Conclusion: Film spray containing curcumin possesses multiple actions against SARS-CoV-2 infection by inhibiting ACE-2 binding in target cells and enhancing mucosal innate immunity. The film spray can also inhibit influenza virus infection. Therefore, the curcumin film spray may be effective in preventing the viral infection of both SARS-CoV-2 and influenza.
Keywords: COVID-19; Curcumin; Influenza; Mucosal immunity; SARS-CoV-2.
. 2024 Jan 23;21(1):26.
doi: 10.1186/s12985-023-02282-x. A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity
Wipawee Nittayananta[SUP] 1 [/SUP], Hatairat Lerdsamran[SUP] 2 [/SUP], Nopporn Chutiwitoonchai[SUP] 3 [/SUP], Aornrutai Promsong[SUP] 4 [/SUP], Teerapol Srichana[SUP] 5 6 [/SUP], Kesinee Netsomboon[SUP] 7 [/SUP], Jarunee Prasertsopon[SUP] 2 [/SUP], Jaruta Kerdto[SUP] 8 [/SUP]
Affiliations
- PMID: 38263162
- DOI: 10.1186/s12985-023-02282-x
Background: Infection by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and influenza virus is still a major worldwide health concern. Plants are a good source of bioactive compounds to be used as preventive measures for both inhibiting the virus binding and enhancing mucosal innate immunity. Curcumin has been shown to possess antiviral activity and modulate innate immunity. Therefore, the purpose of this study was to develop an oro-nasal film spray containing curcumin and determine its antiviral activity against SARS-CoV-2 and influenza virus infection, as well as its effects on mucosal innate immunity and inflammatory cytokines in vitro.
Methods: The antiviral activity of the film spray against SARS-CoV-2, influenza A/H1N1, A/H3N2, and influenza B was assessed in vitro by plaque reduction assay. Cytotoxicity of the film spray to oral keratinocytes and nasal epithelial cells was assessed by MTT assay, and cytotoxicity to Vero and MDCK cells was assessed by an MTS-based cytotoxicity assay. Oral and nasal innate immune markers in response to the film spray were determined by ELISA and by a commercial Milliplex Map Kit, respectively.
Results: Our data show that the film spray containing curcumin can inhibit both SARS-CoV-2 and influenza virus infections while maintaining cell viability. Results obtained among 4 viruses revealed that curcumin film spray demonstrated the highest inhibitory activity against SARS-CoV-2 with the lowest EC[SUB]50[/SUB] of 3.15 µg/ml and the highest SI value of 4.62, followed by influenza B (EC[SUB]50[/SUB] = 6.32 µg/ml, SI = 2.04), influenza A/H1N1 (EC[SUB]50[/SUB] = 7.24 µg/ml, SI = 1.78), and influenza A/H3N2 (EC[SUB]50[/SUB] > 12.5 µg/ml, SI < 1.03), respectively. Antimicrobial peptides LL-37 and HD-5, IL-6 and TNF-α produced by oral keratinocytes were significantly induced by the film spray, while hBD2 was significantly reduced.
Conclusion: Film spray containing curcumin possesses multiple actions against SARS-CoV-2 infection by inhibiting ACE-2 binding in target cells and enhancing mucosal innate immunity. The film spray can also inhibit influenza virus infection. Therefore, the curcumin film spray may be effective in preventing the viral infection of both SARS-CoV-2 and influenza.
Keywords: COVID-19; Curcumin; Influenza; Mucosal immunity; SARS-CoV-2.